Back to Search
Start Over
Medication safety and the administration of intravenous vincristine: international survey of oncology pharmacists.
- Source :
-
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2015 Feb; Vol. 21 (1), pp. 10-8. Date of Electronic Publication: 2014 Jan 13. - Publication Year :
- 2015
-
Abstract
- Purpose: The risk of medication errors with vincristine administration is well documented. Our objective was to ascertain how vincristine is administered worldwide and determine what strategies for preventing the accidental intrathecal administration of vincristine are in place.<br />Methods: A survey, comprising 28 questions, was distributed to 363 International Society of Oncology Pharmacy Practitioners members from 42 countries via email. Questions were asked on methods of vincristine administration, intrathecal drug administration and strategies used to prevent medication errors. A reminder was sent and the survey was available on the International Society of Oncology Pharmacy Practitioners website. Only one survey per institution was requested.<br />Results: In all, 62 responses from 15 countries were received, with the majority from Australia. Vincristine was dispensed in mini-bags in 77.4% of centres, though some also used syringes. Syringes were used in 31.1% of centres, with half these doses prepared undiluted. Administration took 5 to 15 minutes in most centres (78.8%). The most common reasons for still using syringes were perceived risk of extravasation and faster infusion time. Despite numerous vincristine administrations, extravasation was very rare. Other recommended strategies for error prevention were in use in the majority of centres.<br />Conclusion: Comparisons with three previous surveys are difficult as the majority of respondents in those studies were from the USA. A number of areas appear to have improved, particularly the preparation of vincristine in mini-bags, but they are far from perfect. Deaths continue to occur following accidental intrathecal administration of vincristine. International Society of Oncology Pharmacy Practitioner members are urged to lead the way in incorporating strategies for prevention into institutions worldwide.<br /> (© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.)
- Subjects :
- Antineoplastic Agents, Phytogenic administration & dosage
Antineoplastic Agents, Phytogenic adverse effects
Data Collection
Humans
Infusions, Intravenous adverse effects
Infusions, Intravenous methods
Infusions, Intravenous standards
Medical Oncology methods
Patient Safety statistics & numerical data
Pharmacists standards
Surveys and Questionnaires
Vincristine administration & dosage
Vincristine adverse effects
Antineoplastic Agents, Phytogenic therapeutic use
Medical Oncology statistics & numerical data
Medication Errors prevention & control
Pharmacists statistics & numerical data
Vincristine therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1477-092X
- Volume :
- 21
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
- Publication Type :
- Academic Journal
- Accession number :
- 24418800
- Full Text :
- https://doi.org/10.1177/1078155213517729